Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England

Stephen W. Duffy, Laszlo Tabar, Anne Helene Olsen, Bedrich Vitak, Prue C. Allgood, Tony H H Chen, Amy M F Yen, Robert A. Smith

Research output: Contribution to journalArticle

173 Citations (Scopus)

Abstract

Objectives To estimate the absolute numbers of breast cancer deaths prevented and the absolute numbers of tumours overdiagnosed in mammographic screening for breast cancer at ages 50-69 years. Setting The Swedish Two-County randomized trial of mammographic screening for breast cancer, and the UK Breast Screening Programme in England, ages 50-69 years. Methods We estimated the absolute numbers of deaths avoided and additional cases diagnosed in the study group (active study population) of the Swedish Two-County Trial, by comparison with the control group (passive study population). We estimated the same quantities for the mortality and incidence rates in England (1974-2004 and 1974-2003, respectively). We used Poisson regression for statistical inference. Results A substantial and significant reduction in breast cancer mortality was associated with screening in both the Two-County Trial (P <0.001) and the screening programme in England (P <0.001). The absolute benefits were estimated as 8.8 and 5.7 breast cancer deaths prevented per 1000 women screened for 20 years starting at age 50 from the Two-County Trial and screening programme in England, respectively. The corresponding estimated numbers of cases overdiagnosed per 1000 women screened for 20 years were, respectively, 4.3 and 2.3 per 1000. Conclusions The benefit of mammographic screening in terms of lives saved is greater in absolute terms than the harm in terms of overdiagnosis. Between 2 and 2.5 lives are saved for every overdiagnosed case.

Original languageEnglish
Pages (from-to)25-30
Number of pages6
JournalJournal of Medical Screening
Volume17
Issue number1
DOIs
Publication statusPublished - Mar 2010
Externally publishedYes

Fingerprint

Early Detection of Cancer
England
Breast
Breast Neoplasms
Mortality
Population
Medical Overuse
Regression Analysis
Control Groups
Incidence
Neoplasms

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health Policy

Cite this

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. / Duffy, Stephen W.; Tabar, Laszlo; Olsen, Anne Helene; Vitak, Bedrich; Allgood, Prue C.; Chen, Tony H H; Yen, Amy M F; Smith, Robert A.

In: Journal of Medical Screening, Vol. 17, No. 1, 03.2010, p. 25-30.

Research output: Contribution to journalArticle

Duffy, Stephen W. ; Tabar, Laszlo ; Olsen, Anne Helene ; Vitak, Bedrich ; Allgood, Prue C. ; Chen, Tony H H ; Yen, Amy M F ; Smith, Robert A. / Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. In: Journal of Medical Screening. 2010 ; Vol. 17, No. 1. pp. 25-30.
@article{7cf0a5a3d30c4671b5e81678f40d9d81,
title = "Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England",
abstract = "Objectives To estimate the absolute numbers of breast cancer deaths prevented and the absolute numbers of tumours overdiagnosed in mammographic screening for breast cancer at ages 50-69 years. Setting The Swedish Two-County randomized trial of mammographic screening for breast cancer, and the UK Breast Screening Programme in England, ages 50-69 years. Methods We estimated the absolute numbers of deaths avoided and additional cases diagnosed in the study group (active study population) of the Swedish Two-County Trial, by comparison with the control group (passive study population). We estimated the same quantities for the mortality and incidence rates in England (1974-2004 and 1974-2003, respectively). We used Poisson regression for statistical inference. Results A substantial and significant reduction in breast cancer mortality was associated with screening in both the Two-County Trial (P <0.001) and the screening programme in England (P <0.001). The absolute benefits were estimated as 8.8 and 5.7 breast cancer deaths prevented per 1000 women screened for 20 years starting at age 50 from the Two-County Trial and screening programme in England, respectively. The corresponding estimated numbers of cases overdiagnosed per 1000 women screened for 20 years were, respectively, 4.3 and 2.3 per 1000. Conclusions The benefit of mammographic screening in terms of lives saved is greater in absolute terms than the harm in terms of overdiagnosis. Between 2 and 2.5 lives are saved for every overdiagnosed case.",
author = "Duffy, {Stephen W.} and Laszlo Tabar and Olsen, {Anne Helene} and Bedrich Vitak and Allgood, {Prue C.} and Chen, {Tony H H} and Yen, {Amy M F} and Smith, {Robert A.}",
year = "2010",
month = "3",
doi = "10.1258/jms.2009.009094",
language = "English",
volume = "17",
pages = "25--30",
journal = "Journal of Medical Screening",
issn = "0969-1413",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England

AU - Duffy, Stephen W.

AU - Tabar, Laszlo

AU - Olsen, Anne Helene

AU - Vitak, Bedrich

AU - Allgood, Prue C.

AU - Chen, Tony H H

AU - Yen, Amy M F

AU - Smith, Robert A.

PY - 2010/3

Y1 - 2010/3

N2 - Objectives To estimate the absolute numbers of breast cancer deaths prevented and the absolute numbers of tumours overdiagnosed in mammographic screening for breast cancer at ages 50-69 years. Setting The Swedish Two-County randomized trial of mammographic screening for breast cancer, and the UK Breast Screening Programme in England, ages 50-69 years. Methods We estimated the absolute numbers of deaths avoided and additional cases diagnosed in the study group (active study population) of the Swedish Two-County Trial, by comparison with the control group (passive study population). We estimated the same quantities for the mortality and incidence rates in England (1974-2004 and 1974-2003, respectively). We used Poisson regression for statistical inference. Results A substantial and significant reduction in breast cancer mortality was associated with screening in both the Two-County Trial (P <0.001) and the screening programme in England (P <0.001). The absolute benefits were estimated as 8.8 and 5.7 breast cancer deaths prevented per 1000 women screened for 20 years starting at age 50 from the Two-County Trial and screening programme in England, respectively. The corresponding estimated numbers of cases overdiagnosed per 1000 women screened for 20 years were, respectively, 4.3 and 2.3 per 1000. Conclusions The benefit of mammographic screening in terms of lives saved is greater in absolute terms than the harm in terms of overdiagnosis. Between 2 and 2.5 lives are saved for every overdiagnosed case.

AB - Objectives To estimate the absolute numbers of breast cancer deaths prevented and the absolute numbers of tumours overdiagnosed in mammographic screening for breast cancer at ages 50-69 years. Setting The Swedish Two-County randomized trial of mammographic screening for breast cancer, and the UK Breast Screening Programme in England, ages 50-69 years. Methods We estimated the absolute numbers of deaths avoided and additional cases diagnosed in the study group (active study population) of the Swedish Two-County Trial, by comparison with the control group (passive study population). We estimated the same quantities for the mortality and incidence rates in England (1974-2004 and 1974-2003, respectively). We used Poisson regression for statistical inference. Results A substantial and significant reduction in breast cancer mortality was associated with screening in both the Two-County Trial (P <0.001) and the screening programme in England (P <0.001). The absolute benefits were estimated as 8.8 and 5.7 breast cancer deaths prevented per 1000 women screened for 20 years starting at age 50 from the Two-County Trial and screening programme in England, respectively. The corresponding estimated numbers of cases overdiagnosed per 1000 women screened for 20 years were, respectively, 4.3 and 2.3 per 1000. Conclusions The benefit of mammographic screening in terms of lives saved is greater in absolute terms than the harm in terms of overdiagnosis. Between 2 and 2.5 lives are saved for every overdiagnosed case.

UR - http://www.scopus.com/inward/record.url?scp=77950673205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950673205&partnerID=8YFLogxK

U2 - 10.1258/jms.2009.009094

DO - 10.1258/jms.2009.009094

M3 - Article

C2 - 20356942

AN - SCOPUS:77950673205

VL - 17

SP - 25

EP - 30

JO - Journal of Medical Screening

JF - Journal of Medical Screening

SN - 0969-1413

IS - 1

ER -